Artificial Intelligence (AI) Stocks Performance Guide: Recursion Pharmaceuticals (RXRX)
RXRX has no dividends.
Table and Chart of RXRX Performance
See what a $1,000 investment in RXRX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| RXRX Returns | |
|---|---|
| Start Date | May-28-2021 |
| Start Price | $26.36 |
| End Date | Oct-15-2024 |
| End Price | $6.67 |
| # Prices | 42 |
| Min Date | Apr-28-2023 |
| Min Price | $4.77 |
| Max Date | Jun-30-2021 |
| Max Price | $36.50 |
| Total Return | -74.70% |
| Annualized Return | -32.47% |
| Current Value of $1,000 Purchase | $253 |
| Number Returns | 861 |
| Average Return | -19.43% |
| Number Profitable Returns | 240 |
| Percent Profitable Returns | 27.87% |
| Number Unprofitable Returns | 621 |
| Percent Unprofitable Returns | 72.13% |
| Profitable to Unprofitable Returns Ratio | 0.39 |
| RXRX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -5.310 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -364948000 |
| PE to Growth Ratio | None |
| Price to Book | 39.47 |
| PRICE DATA | |
| 52 Week High | $0.797 |
| 52 Week Low | $15.74 |
| Analyst Target Price | $0.309 |
| 50-Day Moving Average | $4.97 |
| 200-Day Moving Average | $6.68 |
| FINANCIAL DATA | |
| Revenue per Share | $-1.66 |
| Revenue | $-1 |
| Profit Margin | 21.8% |
| Return on Equity | -34.4% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
RXRX Compare Returns with S&P 500
RXRX Trendline Chart
RXRX Moving Average Chart
RXRX Stock Return Map - See Patterns of Gains and Losses
RXRX Stock Returns/Purchase Dates